Visual Evoked Potentials in Neuromyelitis Optica Spectrum Disorder.

被引：0
|
作者：
Kim, Nam-Hee [1 ]
Park, Cheol-Yong [2 ]
Shin, Young-Joo [4 ]
Jeong, Kyoung Sook [3 ]
Kim, Ho Jin [5 ]
机构：
[1] Dongguk Univ, Dept Neurol, Grad Sch Med, Seoul, South Korea
[2] Dongguk Univ, Dept Opthalmol, Grad Sch Med, Seoul, South Korea
[3] Dongguk Univ, Dept Occipat & Environm Med, Grad Sch Med, Seoul, South Korea
[4] Hallym Univ, Dept Ophthalmol, Coll Med, Chunchon, South Korea
[5] Natl Canc Ctr, Dept Neurol, Singapore, Singapore
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-81
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [41] Delayed Visual Improvement in Neuromyelitis Optica Spectrum Disorder With Severe Optic Atrophy
    Ong, Joshua
    Mortensen, Peter
    Raviskanthan, Subahari
    Pakravan, Mohammad
    Charoenkijkajorn, Chaow
    Davila-Siliezar, Pamela
    Laylani, Noor A.
    Lee, Andrew G.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2024, 44 (03) : E348 - E349
  • [42] Multimodal imaging analyses in neuromyelitis optica spectrum disorder with or without visual disturbance
    Nakaya, Moto
    Sato, Noriko
    Suzuki, Fumio
    Maikusa, Norihide
    Matsuda, Hiroshi
    Kimura, Yukio
    Shigemoto, Yoko
    Chiba, Emiko
    Ota, Miho
    Yamamura, Takashi
    Sato, Wakiro
    Okamoto, Tomoko
    Abe, Osamu
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 462
  • [43] Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Fung, Simon
    Shirley, Matt
    CNS DRUGS, 2023, 37 (04) : 363 - 370
  • [44] Inebilizumab for treatment of neuromyelitis optica spectrum disorder
    Tullman, Mark J.
    Zabeti, Aram
    Vuocolo, Scott
    Dinh, Quinn
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (05) : 341 - 352
  • [45] Pregnancy outcomes in neuromyelitis optica spectrum disorder
    Vishnevetsky, A.
    Levy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 140 - 140
  • [46] Satralizumab in the treatment of neuromyelitis optica spectrum disorder
    Duchow, Ankelien
    Bellmann-Strobl, Judith
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) : 49 - 59
  • [47] Cyclophosphamide treatment in Neuromyelitis Optica Spectrum Disorder
    Gulluoglu, H.
    Uysal, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 798 - 798
  • [48] Urinalysis in patients with neuromyelitis optica spectrum disorder
    Chen, Z. G.
    Huang, J.
    Fan, R.
    Weng, R. H.
    Shinohara, R. T.
    Landis, J. R.
    Chen, Y.
    Jiang, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (04) : 619 - 625
  • [49] Frequency of comorbidities in Neuromyelitis Optica spectrum disorder
    Barzegar, Mahdi
    Mirmosayyeb, Omid
    Nehzat, Nasim
    Vaheb, Saeed
    Shaygannejad, Vahid
    Asgari, Nasrin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [50] A new era for neuromyelitis optica spectrum disorder
    Silbermann, Elizabeth
    Bourdette, Dennis
    LANCET, 2019, 394 (10206): : 1304 - 1305
12345